世界の神経刺激装置市場予測2023-2029:据え置き型神経刺激装置、携帯型神経刺激装置

【英語タイトル】Neurostimulator Device Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5365)・商品コード:MMG23JU5365
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:76
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の神経刺激装置市場規模と予測を収録しています。・世界の神経刺激装置市場:売上、2018年-2023年、2024年-2029年
・世界の神経刺激装置市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の神経刺激装置市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「据え置き型神経刺激装置」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

神経刺激装置のグローバル主要企業は、Cyberonics、 Abiomed、 MED-EL、 Philips Healthcare、 Cardiac Science、 Zoll Medical、 Schiller、 Nihon Kohden、 GE Healthcare、 Cochlear、 Boston Scientific、 Biotronik、 Sorin Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、神経刺激装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の神経刺激装置市場:タイプ別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場:タイプ別市場シェア、2022年
・据え置き型神経刺激装置、携帯型神経刺激装置

世界の神経刺激装置市場:用途別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場:用途別市場シェア、2022年
・病院、科学研究、その他

世界の神経刺激装置市場:地域・国別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における神経刺激装置のグローバル売上、2018年-2023年
・主要企業における神経刺激装置のグローバル売上シェア、2022年
・主要企業における神経刺激装置のグローバル販売量、2018年-2023年
・主要企業における神経刺激装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Cyberonics、 Abiomed、 MED-EL、 Philips Healthcare、 Cardiac Science、 Zoll Medical、 Schiller、 Nihon Kohden、 GE Healthcare、 Cochlear、 Boston Scientific、 Biotronik、 Sorin Group

*************************************************************

・調査・分析レポートの概要
神経刺激装置市場の定義
市場セグメント
世界の神経刺激装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の神経刺激装置市場規模
世界の神経刺激装置市場規模:2022年 VS 2029年
世界の神経刺激装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの神経刺激装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の神経刺激装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:据え置き型神経刺激装置、携帯型神経刺激装置
神経刺激装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、科学研究、その他
神経刺激装置の用途別グローバル売上・予測

・地域別市場分析
地域別神経刺激装置市場規模 2022年と2029年
地域別神経刺激装置売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Cyberonics、 Abiomed、 MED-EL、 Philips Healthcare、 Cardiac Science、 Zoll Medical、 Schiller、 Nihon Kohden、 GE Healthcare、 Cochlear、 Boston Scientific、 Biotronik、 Sorin Group
...

This report aims to provide a comprehensive presentation of the global market for Neurostimulator Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulator Device. This report contains market size and forecasts of Neurostimulator Device in global, including the following market information:
Global Neurostimulator Device Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Neurostimulator Device Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Neurostimulator Device companies in 2022 (%)
The global Neurostimulator Device market was valued at US$ 6832.2 million in 2022 and is projected to reach US$ 13830 million by 2029, at a CAGR of 10.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Stationary Neurostimulator Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neurostimulator Device include Cyberonics, Abiomed, MED-EL, Philips Healthcare, Cardiac Science, Zoll Medical, Schiller, Nihon Kohden and GE Healthcare, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurostimulator Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurostimulator Device Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurostimulator Device Market Segment Percentages, by Type, 2022 (%)
Stationary Neurostimulator
Portable Neurostimulator
Global Neurostimulator Device Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurostimulator Device Market Segment Percentages, by Application, 2022 (%)
Hospital
Scientific Research
Other
Global Neurostimulator Device Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurostimulator Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurostimulator Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neurostimulator Device revenues share in global market, 2022 (%)
Key companies Neurostimulator Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Neurostimulator Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cyberonics
Abiomed
MED-EL
Philips Healthcare
Cardiac Science
Zoll Medical
Schiller
Nihon Kohden
GE Healthcare
Cochlear
Boston Scientific
Biotronik
Sorin Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurostimulator Device, market overview.
Chapter 2: Global Neurostimulator Device market size in revenue and volume.
Chapter 3: Detailed analysis of Neurostimulator Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurostimulator Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neurostimulator Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Neurostimulator Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurostimulator Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurostimulator Device Overall Market Size
2.1 Global Neurostimulator Device Market Size: 2022 VS 2029
2.2 Global Neurostimulator Device Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Neurostimulator Device Sales: 2018-2029
3 Company Landscape
3.1 Top Neurostimulator Device Players in Global Market
3.2 Top Global Neurostimulator Device Companies Ranked by Revenue
3.3 Global Neurostimulator Device Revenue by Companies
3.4 Global Neurostimulator Device Sales by Companies
3.5 Global Neurostimulator Device Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Neurostimulator Device Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Neurostimulator Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurostimulator Device Players in Global Market
3.8.1 List of Global Tier 1 Neurostimulator Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurostimulator Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Neurostimulator Device Market Size Markets, 2022 & 2029
4.1.2 Stationary Neurostimulator
4.1.3 Portable Neurostimulator
4.2 By Type – Global Neurostimulator Device Revenue & Forecasts
4.2.1 By Type – Global Neurostimulator Device Revenue, 2018-2023
4.2.2 By Type – Global Neurostimulator Device Revenue, 2024-2029
4.2.3 By Type – Global Neurostimulator Device Revenue Market Share, 2018-2029
4.3 By Type – Global Neurostimulator Device Sales & Forecasts
4.3.1 By Type – Global Neurostimulator Device Sales, 2018-2023
4.3.2 By Type – Global Neurostimulator Device Sales, 2024-2029
4.3.3 By Type – Global Neurostimulator Device Sales Market Share, 2018-2029
4.4 By Type – Global Neurostimulator Device Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Neurostimulator Device Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Other
5.2 By Application – Global Neurostimulator Device Revenue & Forecasts
5.2.1 By Application – Global Neurostimulator Device Revenue, 2018-2023
5.2.2 By Application – Global Neurostimulator Device Revenue, 2024-2029
5.2.3 By Application – Global Neurostimulator Device Revenue Market Share, 2018-2029
5.3 By Application – Global Neurostimulator Device Sales & Forecasts
5.3.1 By Application – Global Neurostimulator Device Sales, 2018-2023
5.3.2 By Application – Global Neurostimulator Device Sales, 2024-2029
5.3.3 By Application – Global Neurostimulator Device Sales Market Share, 2018-2029
5.4 By Application – Global Neurostimulator Device Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Neurostimulator Device Market Size, 2022 & 2029
6.2 By Region – Global Neurostimulator Device Revenue & Forecasts
6.2.1 By Region – Global Neurostimulator Device Revenue, 2018-2023
6.2.2 By Region – Global Neurostimulator Device Revenue, 2024-2029
6.2.3 By Region – Global Neurostimulator Device Revenue Market Share, 2018-2029
6.3 By Region – Global Neurostimulator Device Sales & Forecasts
6.3.1 By Region – Global Neurostimulator Device Sales, 2018-2023
6.3.2 By Region – Global Neurostimulator Device Sales, 2024-2029
6.3.3 By Region – Global Neurostimulator Device Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Neurostimulator Device Revenue, 2018-2029
6.4.2 By Country – North America Neurostimulator Device Sales, 2018-2029
6.4.3 US Neurostimulator Device Market Size, 2018-2029
6.4.4 Canada Neurostimulator Device Market Size, 2018-2029
6.4.5 Mexico Neurostimulator Device Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Neurostimulator Device Revenue, 2018-2029
6.5.2 By Country – Europe Neurostimulator Device Sales, 2018-2029
6.5.3 Germany Neurostimulator Device Market Size, 2018-2029
6.5.4 France Neurostimulator Device Market Size, 2018-2029
6.5.5 U.K. Neurostimulator Device Market Size, 2018-2029
6.5.6 Italy Neurostimulator Device Market Size, 2018-2029
6.5.7 Russia Neurostimulator Device Market Size, 2018-2029
6.5.8 Nordic Countries Neurostimulator Device Market Size, 2018-2029
6.5.9 Benelux Neurostimulator Device Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Neurostimulator Device Revenue, 2018-2029
6.6.2 By Region – Asia Neurostimulator Device Sales, 2018-2029
6.6.3 China Neurostimulator Device Market Size, 2018-2029
6.6.4 Japan Neurostimulator Device Market Size, 2018-2029
6.6.5 South Korea Neurostimulator Device Market Size, 2018-2029
6.6.6 Southeast Asia Neurostimulator Device Market Size, 2018-2029
6.6.7 India Neurostimulator Device Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Neurostimulator Device Revenue, 2018-2029
6.7.2 By Country – South America Neurostimulator Device Sales, 2018-2029
6.7.3 Brazil Neurostimulator Device Market Size, 2018-2029
6.7.4 Argentina Neurostimulator Device Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Neurostimulator Device Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Neurostimulator Device Sales, 2018-2029
6.8.3 Turkey Neurostimulator Device Market Size, 2018-2029
6.8.4 Israel Neurostimulator Device Market Size, 2018-2029
6.8.5 Saudi Arabia Neurostimulator Device Market Size, 2018-2029
6.8.6 UAE Neurostimulator Device Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cyberonics
7.1.1 Cyberonics Company Summary
7.1.2 Cyberonics Business Overview
7.1.3 Cyberonics Neurostimulator Device Major Product Offerings
7.1.4 Cyberonics Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.1.5 Cyberonics Key News & Latest Developments
7.2 Abiomed
7.2.1 Abiomed Company Summary
7.2.2 Abiomed Business Overview
7.2.3 Abiomed Neurostimulator Device Major Product Offerings
7.2.4 Abiomed Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.2.5 Abiomed Key News & Latest Developments
7.3 MED-EL
7.3.1 MED-EL Company Summary
7.3.2 MED-EL Business Overview
7.3.3 MED-EL Neurostimulator Device Major Product Offerings
7.3.4 MED-EL Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.3.5 MED-EL Key News & Latest Developments
7.4 Philips Healthcare
7.4.1 Philips Healthcare Company Summary
7.4.2 Philips Healthcare Business Overview
7.4.3 Philips Healthcare Neurostimulator Device Major Product Offerings
7.4.4 Philips Healthcare Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.4.5 Philips Healthcare Key News & Latest Developments
7.5 Cardiac Science
7.5.1 Cardiac Science Company Summary
7.5.2 Cardiac Science Business Overview
7.5.3 Cardiac Science Neurostimulator Device Major Product Offerings
7.5.4 Cardiac Science Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.5.5 Cardiac Science Key News & Latest Developments
7.6 Zoll Medical
7.6.1 Zoll Medical Company Summary
7.6.2 Zoll Medical Business Overview
7.6.3 Zoll Medical Neurostimulator Device Major Product Offerings
7.6.4 Zoll Medical Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.6.5 Zoll Medical Key News & Latest Developments
7.7 Schiller
7.7.1 Schiller Company Summary
7.7.2 Schiller Business Overview
7.7.3 Schiller Neurostimulator Device Major Product Offerings
7.7.4 Schiller Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.7.5 Schiller Key News & Latest Developments
7.8 Nihon Kohden
7.8.1 Nihon Kohden Company Summary
7.8.2 Nihon Kohden Business Overview
7.8.3 Nihon Kohden Neurostimulator Device Major Product Offerings
7.8.4 Nihon Kohden Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.8.5 Nihon Kohden Key News & Latest Developments
7.9 GE Healthcare
7.9.1 GE Healthcare Company Summary
7.9.2 GE Healthcare Business Overview
7.9.3 GE Healthcare Neurostimulator Device Major Product Offerings
7.9.4 GE Healthcare Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.9.5 GE Healthcare Key News & Latest Developments
7.10 Cochlear
7.10.1 Cochlear Company Summary
7.10.2 Cochlear Business Overview
7.10.3 Cochlear Neurostimulator Device Major Product Offerings
7.10.4 Cochlear Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.10.5 Cochlear Key News & Latest Developments
7.11 Boston Scientific
7.11.1 Boston Scientific Company Summary
7.11.2 Boston Scientific Neurostimulator Device Business Overview
7.11.3 Boston Scientific Neurostimulator Device Major Product Offerings
7.11.4 Boston Scientific Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.11.5 Boston Scientific Key News & Latest Developments
7.12 Biotronik
7.12.1 Biotronik Company Summary
7.12.2 Biotronik Neurostimulator Device Business Overview
7.12.3 Biotronik Neurostimulator Device Major Product Offerings
7.12.4 Biotronik Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.12.5 Biotronik Key News & Latest Developments
7.13 Sorin Group
7.13.1 Sorin Group Company Summary
7.13.2 Sorin Group Neurostimulator Device Business Overview
7.13.3 Sorin Group Neurostimulator Device Major Product Offerings
7.13.4 Sorin Group Neurostimulator Device Sales and Revenue in Global (2018-2023)
7.13.5 Sorin Group Key News & Latest Developments
8 Global Neurostimulator Device Production Capacity, Analysis
8.1 Global Neurostimulator Device Production Capacity, 2018-2029
8.2 Neurostimulator Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurostimulator Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurostimulator Device Supply Chain Analysis
10.1 Neurostimulator Device Industry Value Chain
10.2 Neurostimulator Device Upstream Market
10.3 Neurostimulator Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurostimulator Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界の神経刺激装置市場予測2023-2029:据え置き型神経刺激装置、携帯型神経刺激装置] (コード:MMG23JU5365)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経刺激装置市場予測2023-2029:据え置き型神経刺激装置、携帯型神経刺激装置]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆